We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-4.19%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$26.1B
AUM Growth
-$4.09B
(-14%)
Cap. Flow
-$2.77B
Cap. Flow
% of AUM
-10.63%
Top 10 Holdings %
Top 10 Hldgs %
22.95%
Holding
1,846
New
56
Increased
388
Reduced
1,301
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$49.4M |
| 2 |
Nucor
NUE
|
+$35.6M |
| 3 |
Essex Property Trust
ESS
|
+$27.5M |
| 4 |
Archer Daniels Midland
ADM
|
+$27.3M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$21.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$366M |
| 2 |
Microsoft
MSFT
|
+$279M |
| 3 |
Amazon
AMZN
|
+$213M |
| 4 |
Tesla
TSLA
|
+$109M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.74% |
| 2 | Consumer Staples | 11.79% |
| 3 | Consumer Discretionary | 11.57% |
| 4 | Industrials | 10.74% |
| 5 | Healthcare | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Archer Aviation
ACHR
$3.64B
| $41K | ﹤0.01% |
15,686
+1,699
| +12% | +$5.97K |
|
1677
MacroGenics
MGNX
$235M
| $41K | ﹤0.01% |
11,815
+266
| +2% | +$1.02K |
|
1678
Xeris Biopharma Holdings
XERS
$1.44B
| $41K | ﹤0.01% |
26,029
+601
| +2% | +$994 |
|
1679
Enviri
NVRI
$621M
| $40K | ﹤0.01% |
10,822
-279
| -3% | -$1.55K |
|
1680
Rigel Pharmaceuticals
RIGL
$680M
| $40K | ﹤0.01% |
3,356
+77
| +2% | +$1.04K |
|
|
CORZ
1681
DELISTED
Core Scientific, Inc. Common Stock
CORZ
| $39K | ﹤0.01% |
29,598
+5,015
| +20% | +$10.7K |
|
|
VCSA
1682
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $38K | ﹤0.01% |
+616
| New | +$42.7K |
|
1683
Community Health Systems
CYH
$385M
| $37K | ﹤0.01% |
17,197
-485
| -3% | -$1.61K |
|
|
HLTH
1684
DELISTED
Cue Health Inc. Common Stock
HLTH
| $37K | ﹤0.01% |
12,003
-104
| -0.9% | -$369 |
|
|
AMRN
1685
Amarin Corp
AMRN
$284M
| $36K | ﹤0.01% |
1,663
+124
| +8% | +$3.33K |
|
|
FSP
1686
Franklin Street Properties
FSP
$44.8M
| $36K | ﹤0.01% |
13,387
-370
| -3% | -$1.22K |
|
1687
MiMedx Group
MDXG
$626M
| $36K | ﹤0.01% |
12,437
-238
| -2% | -$846 |
|
|
FIRY
1688
Firy Inc
FIRY
$127M
| $35K | ﹤0.01% |
1,732
+15
| +0.9% | +$423 |
|
|
SOND
1689
DELISTED
Sonder
SOND
| $35K | ﹤0.01% |
+1,044
| New | +$34.7K |
|
1690
Humacyte
HUMA
$168M
| $34K | ﹤0.01% |
10,610
+606
| +6% | +$2.32K |
|
1691
Microvast
MVST
$267M
| $34K | ﹤0.01% |
18,470
-686
| -4% | -$1.64K |
|
|
ROVR
1692
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $34K | ﹤0.01% |
10,223
-195
| -2% | -$776 |
|
|
RIDE
1693
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $34K | ﹤0.01% |
1,229
+33
| +3% | +$1.05K |
|
1694
Nautilus Biotechnolgy
NAUT
$215M
| $33K | ﹤0.01% |
15,740
+691
| +5% | +$1.74K |
|
1695
Smartbird Inc
BIRD
$21.7M
| $32K | ﹤0.01% |
532
+2
| +0.4% | +$177 |
|
|
DHC
1696
Diversified Healthcare Trust
DHC
$2.26B
| $32K | ﹤0.01% |
32,733
-845
| -3% | -$1.35K |
|
|
CMRX
1697
DELISTED
Chimerix, Inc.
CMRX
| $32K | ﹤0.01% |
16,650
+381
| +2% | +$855 |
|
|
TDAY
1698
USA Today Co
TDAY
$1.23B
| $31K | ﹤0.01% |
19,723
-660
| -3% | -$1.6K |
|
1699
Alaunos Therapeutics
TCRT
$4.74M
| $31K | ﹤0.01% |
121
+9
| +8% | +$2.61K |
|
1700
Nuvation Bio
NUVB
$2.24B
| $30K | ﹤0.01% |
12,830
-245
| -2% | -$700 |
|
Similar funds
ProShare Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, ProShare Advisors held 1,846 positions worth $26.1B, down 14% from $30.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
ProShare Advisors withdrew a net $2.77B in Q3 2022, closing 96 positions and reducing 1,301 holdings. Its most notable exit was Neenah, Inc. Common Stock, an estimated $7.52M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, ProShare Advisors opened a new position in Xometry worth $7.31M.
- ProShare Advisors's largest Q3 2022 buy was Xometry: 128,758 shares worth $7.31M.
- ProShare Advisors added most to Target in Q3 2022, an estimated $49.4M increase.
- ProShare Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $366M.
- ProShare Advisors fully exited Neenah, Inc. Common Stock in Q3 2022, selling an estimated $7.52M.
- ProShare Advisors's ten largest holdings make up 23% of its $26.1B portfolio in Q3 2022.
- ProShare Advisors opened 56 new positions and closed 96 in Q3 2022.
- ProShare Advisors's portfolio value fell 14% quarter-over-quarter to $26.1B.
Based on ProShare Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.